Clonorchiasis Companies

ID: MRFR/Pharma/3265-HCR

110 Pages

Rahul Gotadki

October 2025

Clonorchiasis is a parasitic infection caused by the liver fluke Clonorchis sinensis. The infection is typically acquired by consuming raw or undercooked freshwater fish that harbor the infective stage of the parasite. While there are no specific companies solely dedicated to clonorchiasis, pharmaceutical companies, research institutions, and health organizations may be involved in the development of diagnostic tools, treatments, and prevention strategies for parasitic infections, including clonorchiasis.

Clonorchiasis Market Research Report-Forecast Till 2032 Infographic

Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Clonorchiasis Market

Clonorchiasis Key Companies

Latest Clonorchiasis Companies Update

Merck and Johnson & Johnson contribute to public health initiatives in endemic regions, improving access to basic healthcare and sanitation infrastructure.

World Health Organization (WHO) and the Bill & Melinda Gates Foundation are actively involved in funding research, promoting control programs, and raising awareness about Clonorchiasis.

List of Clonorchiasis Key Companies in the Market

Pfizer (U.S)

Bayer AG (Germany)

Provet (Switzerland)

Virbac (India)

Cipla (India)

Novartis AG (Switzerland)

CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India)

Merck & Co. Inc. (U.S.)

Hoffmann-La Roche Ltd. (Switzerland)

Abbott (U.S.)

Arsanis Inc. (Austria)

Novabiotics (U.K.)

GlaxoSmithKline plc. (U.K.)

Teva Pharmaceutical Industries Ltd (Taiwan)